| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 8.71e-06 | 25 | 106 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.13e-04 | 303 | 106 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.88e-04 | 27 | 106 | 3 | GO:0008139 | |
| GeneOntologyBiologicalProcess | snRNA metabolic process | 1.31e-05 | 59 | 106 | 5 | GO:0016073 | |
| GeneOntologyBiologicalProcess | U6 snRNA 3'-end processing | 2.62e-05 | 2 | 106 | 2 | GO:0034477 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 7.82e-05 | 3 | 106 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FLT3LG PATZ1 NACA AKNA ELL3 E2F8 KMT2D EGR2 BRD4 MED25 SIX5 MLLT6 MAML2 MED26 NOTCH1 NOTCH2 NOTCH3 NPAS2 ZNF646 | 7.84e-05 | 1390 | 106 | 19 | GO:0045944 |
| Domain | DUF3454 | 1.63e-07 | 3 | 103 | 3 | PF11936 | |
| Domain | DUF3454_notch | 1.63e-07 | 3 | 103 | 3 | IPR024600 | |
| Domain | DUF3454 | 1.63e-07 | 3 | 103 | 3 | SM01334 | |
| Domain | Notch | 6.49e-07 | 4 | 103 | 3 | IPR008297 | |
| Domain | NODP | 6.49e-07 | 4 | 103 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 6.49e-07 | 4 | 103 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 6.49e-07 | 4 | 103 | 3 | IPR010660 | |
| Domain | NOD | 6.49e-07 | 4 | 103 | 3 | PF06816 | |
| Domain | NOD | 6.49e-07 | 4 | 103 | 3 | SM01338 | |
| Domain | NODP | 6.49e-07 | 4 | 103 | 3 | SM01339 | |
| Domain | LNR | 1.62e-06 | 5 | 103 | 3 | PS50258 | |
| Domain | Notch_dom | 5.61e-06 | 7 | 103 | 3 | IPR000800 | |
| Domain | Notch | 5.61e-06 | 7 | 103 | 3 | PF00066 | |
| Domain | NL | 5.61e-06 | 7 | 103 | 3 | SM00004 | |
| Domain | ASX_HYDROXYL | 1.90e-05 | 100 | 103 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.65e-05 | 106 | 103 | 6 | IPR000152 | |
| Domain | Znf_C2H2_matrin | 3.46e-05 | 12 | 103 | 3 | IPR000690 | |
| Domain | EGF_3 | 4.75e-05 | 235 | 103 | 8 | PS50026 | |
| Domain | EGF | 7.01e-05 | 126 | 103 | 6 | PF00008 | |
| Domain | EGF-like_dom | 7.13e-05 | 249 | 103 | 8 | IPR000742 | |
| Domain | ZF_MATRIN | 1.25e-04 | 18 | 103 | 3 | PS50171 | |
| Domain | ICAM | 1.79e-04 | 4 | 103 | 2 | IPR003988 | |
| Domain | Znf_C2H2_jaz | 2.32e-04 | 22 | 103 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 2.32e-04 | 22 | 103 | 3 | PF12171 | |
| Domain | ICAM_N | 2.98e-04 | 5 | 103 | 2 | IPR013768 | |
| Domain | ICAM_N | 2.98e-04 | 5 | 103 | 2 | PF03921 | |
| Domain | EGF | 3.25e-04 | 235 | 103 | 7 | SM00181 | |
| Domain | ICAM_VCAM_N | 4.45e-04 | 6 | 103 | 2 | IPR003987 | |
| Domain | hEGF | 4.83e-04 | 28 | 103 | 3 | PF12661 | |
| Domain | EGF_1 | 5.30e-04 | 255 | 103 | 7 | PS00022 | |
| Domain | ZnF_U1 | 5.36e-04 | 29 | 103 | 3 | SM00451 | |
| Domain | Znf_U1 | 5.36e-04 | 29 | 103 | 3 | IPR003604 | |
| Domain | EGF_CA | 5.75e-04 | 122 | 103 | 5 | SM00179 | |
| Domain | EGF-like_CS | 6.08e-04 | 261 | 103 | 7 | IPR013032 | |
| Domain | EGF-like_Ca-bd_dom | 6.20e-04 | 124 | 103 | 5 | IPR001881 | |
| Domain | EGF_2 | 6.65e-04 | 265 | 103 | 7 | PS01186 | |
| Domain | EGF_CA | 1.31e-03 | 86 | 103 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.04e-03 | 97 | 103 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.20e-03 | 99 | 103 | 4 | PS01187 | |
| Domain | - | 3.61e-03 | 663 | 103 | 10 | 2.60.40.10 | |
| Domain | Laminin_G | 4.03e-03 | 58 | 103 | 3 | IPR001791 | |
| Domain | EGF_extracell | 4.44e-03 | 60 | 103 | 3 | IPR013111 | |
| Domain | EGF_2 | 4.44e-03 | 60 | 103 | 3 | PF07974 | |
| Domain | - | 5.36e-03 | 20 | 103 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 5.36e-03 | 20 | 103 | 2 | IPR001279 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.00e-07 | 12 | 72 | 4 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 3.00e-07 | 12 | 72 | 4 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 4.32e-07 | 13 | 72 | 4 | M47534 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.27e-06 | 5 | 72 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.81e-06 | 18 | 72 | 4 | M614 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.53e-06 | 6 | 72 | 3 | M27068 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.00e-05 | 27 | 72 | 4 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.17e-05 | 28 | 72 | 4 | M6177 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.05e-05 | 11 | 72 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.52e-05 | 13 | 72 | 3 | M47423 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 9.45e-05 | 47 | 72 | 4 | M7946 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.37e-04 | 20 | 72 | 3 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.10e-04 | 23 | 72 | 3 | MM14954 | |
| Pathway | PID_NOTCH_PATHWAY | 2.30e-04 | 59 | 72 | 4 | M17 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.39e-04 | 24 | 72 | 3 | M11190 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.55e-04 | 5 | 72 | 2 | MM14733 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.62e-04 | 61 | 72 | 4 | M39540 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.71e-04 | 25 | 72 | 3 | M27880 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.51e-04 | 119 | 72 | 5 | M607 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.31e-04 | 7 | 72 | 2 | MM14734 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 5.70e-04 | 32 | 72 | 3 | M29579 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | GATAD2A NUP98 PIDD1 ICE1 NUP214 ELL3 E2F8 KMT2D NUP155 ZNF804B INTS9 MAML2 NOTCH1 NOTCH3 | 5.73e-04 | 1022 | 72 | 14 | MM15436 |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 6.24e-04 | 33 | 72 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 6.82e-04 | 34 | 72 | 3 | M27041 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 6.82e-04 | 34 | 72 | 3 | M39390 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.44e-04 | 35 | 72 | 3 | M27320 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 8.08e-04 | 36 | 72 | 3 | M27245 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 8.08e-04 | 36 | 72 | 3 | M26974 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.10e-04 | 82 | 72 | 4 | MM15922 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 8.76e-04 | 37 | 72 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 8.76e-04 | 37 | 72 | 3 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.02e-03 | 39 | 72 | 3 | M27238 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.02e-03 | 39 | 72 | 3 | MM14604 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.10e-03 | 40 | 72 | 3 | MM14945 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.13e-03 | 10 | 72 | 2 | MM15535 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.18e-03 | 41 | 72 | 3 | M29574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.18e-03 | 41 | 72 | 3 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.27e-03 | 42 | 72 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.36e-03 | 43 | 72 | 3 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.36e-03 | 43 | 72 | 3 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.46e-03 | 44 | 72 | 3 | M109 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.55e-03 | 45 | 72 | 3 | M39571 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.64e-03 | 12 | 72 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.64e-03 | 12 | 72 | 2 | M22042 | |
| Pathway | BIOCARTA_TCYTOTOXIC_PATHWAY | 1.64e-03 | 12 | 72 | 2 | M13247 | |
| Pathway | BIOCARTA_TCYTOTOXIC_PATHWAY | 1.64e-03 | 12 | 72 | 2 | MM1505 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.64e-03 | 12 | 72 | 2 | M27159 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.66e-03 | 46 | 72 | 3 | M27397 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.66e-03 | 46 | 72 | 3 | MM15971 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.76e-03 | 47 | 72 | 3 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.76e-03 | 47 | 72 | 3 | M27395 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.99e-03 | 49 | 72 | 3 | MM14837 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.99e-03 | 49 | 72 | 3 | M618 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.11e-03 | 50 | 72 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.23e-03 | 51 | 72 | 3 | MM15151 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.25e-03 | 14 | 72 | 2 | M27808 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 2.32e-03 | 109 | 72 | 4 | M39542 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.40e-03 | 110 | 72 | 4 | M48259 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.49e-03 | 53 | 72 | 3 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.63e-03 | 54 | 72 | 3 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.77e-03 | 55 | 72 | 3 | MM14917 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.95e-03 | 16 | 72 | 2 | M27121 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.22e-03 | 58 | 72 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.22e-03 | 58 | 72 | 3 | MM14736 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.38e-03 | 59 | 72 | 3 | M27606 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.73e-03 | 18 | 72 | 2 | MM14775 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | GATAD2A PIDD1 ICE1 ZNF619 ELL3 E2F8 KMT2D ZNF804B MED25 INTS9 MAML2 MED26 NOTCH1 NOTCH2 NOTCH3 | 3.85e-03 | 1387 | 72 | 15 | M734 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.45e-03 | 65 | 72 | 3 | MM15147 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.75e-03 | 133 | 72 | 4 | M16476 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 9108364 | ||
| Pubmed | 1.22e-08 | 9 | 111 | 4 | 12370315 | ||
| Pubmed | NACA AAK1 AKNA KIAA1549 ICE1 NRXN3 NUP155 CELSR3 RBM27 AMOT MAML2 HPS5 ZNF646 | 1.56e-08 | 529 | 111 | 13 | 14621295 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 8645602 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 27566587 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 27697639 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 7615640 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 7918097 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 3.16e-08 | 3 | 111 | 3 | 21471519 | |
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 3.16e-08 | 3 | 111 | 3 | 29767458 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 7698746 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 24145721 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.26e-07 | 4 | 111 | 3 | 19404845 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 28669409 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10551863 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.26e-07 | 4 | 111 | 3 | 8898100 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11978185 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 1.26e-07 | 4 | 111 | 3 | 17920003 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.26e-07 | 4 | 111 | 3 | 28061457 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11466531 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 24151014 | ||
| Pubmed | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. | 1.26e-07 | 4 | 111 | 3 | 23999936 | |
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.26e-07 | 4 | 111 | 3 | 10194420 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 18156632 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 1.26e-07 | 4 | 111 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 1.26e-07 | 4 | 111 | 3 | 15917835 | |
| Pubmed | Notch signaling in bulge stem cells is not required for selection of hair follicle fate. | 3.15e-07 | 5 | 111 | 3 | 19211676 | |
| Pubmed | A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | 3.15e-07 | 5 | 111 | 3 | 21562564 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 11101851 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 27040987 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.15e-07 | 5 | 111 | 3 | 15064243 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 23675950 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 15076712 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 12242712 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 15882997 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DPH2 ZBTB4 FBRS AKNA ICE1 NUP214 MBD6 KMT2D CELSR3 BRD4 SAC3D1 MLLT6 ATP2A3 NOTCH1 NOTCH2 KLHL17 | 4.67e-07 | 1105 | 111 | 16 | 35748872 |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 9111338 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 26062937 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 6.28e-07 | 6 | 111 | 3 | 12244553 | |
| Pubmed | Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. | 6.28e-07 | 6 | 111 | 3 | 19573812 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 18299578 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 9882480 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 6.28e-07 | 6 | 111 | 3 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 6.28e-07 | 6 | 111 | 3 | 22615412 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 27460529 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 20870902 | ||
| Pubmed | ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway. | 6.28e-07 | 6 | 111 | 3 | 24671051 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 22526456 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 19503073 | ||
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 6.28e-07 | 6 | 111 | 3 | 11731257 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 6.28e-07 | 6 | 111 | 3 | 19603167 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 20174635 | ||
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 6.28e-07 | 6 | 111 | 3 | 21991352 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 10383933 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.10e-06 | 7 | 111 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.10e-06 | 7 | 111 | 3 | 24711412 | |
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 1.10e-06 | 7 | 111 | 3 | 11518718 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 23079658 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 16169548 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.75e-06 | 8 | 111 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.75e-06 | 8 | 111 | 3 | 15465493 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 9858718 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 11044610 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.75e-06 | 8 | 111 | 3 | 12242716 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.91e-06 | 180 | 111 | 7 | 35198878 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TMEM201 AUP1 RBM33 FBRS NUP98 NUP214 KMT2D NUP155 RBM27 PGLS | 2.20e-06 | 457 | 111 | 10 | 32344865 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.21e-06 | 184 | 111 | 7 | 32908313 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 17573339 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 11118901 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 16245338 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 18507503 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 3.74e-06 | 10 | 111 | 3 | 23665443 | |
| Pubmed | Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. | 3.74e-06 | 10 | 111 | 3 | 28489825 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 15525534 | ||
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 24015274 | ||
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 33915108 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 5.12e-06 | 11 | 111 | 3 | 9187150 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 5.12e-06 | 11 | 111 | 3 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 5.12e-06 | 11 | 111 | 3 | 15499562 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 10878608 | ||
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 12866128 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 15465494 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 10952889 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 32147304 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 14732396 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NUP98 AAK1 ZNF318 NUP214 KMT2D WDHD1 BRD4 PHACTR4 SAC3D1 PRRC2A NOTCH2 IQCK | 7.15e-06 | 774 | 111 | 12 | 15302935 |
| Pubmed | Notch signaling coordinates the patterning of striatal compartments. | 8.84e-06 | 13 | 111 | 3 | 16120638 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 8.84e-06 | 13 | 111 | 3 | 31202705 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 23132245 | ||
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 8.84e-06 | 13 | 111 | 3 | 32929274 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 8.84e-06 | 13 | 111 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 8.84e-06 | 13 | 111 | 3 | 20558824 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 1.01e-05 | 2 | 111 | 2 | 24508387 | |
| Interaction | MAML2 interactions | 1.76e-06 | 17 | 108 | 4 | int:MAML2 | |
| Interaction | PRR20A interactions | 1.98e-06 | 109 | 108 | 7 | int:PRR20A | |
| Interaction | PRR20B interactions | 8.90e-06 | 90 | 108 | 6 | int:PRR20B | |
| Interaction | PRR20C interactions | 8.90e-06 | 90 | 108 | 6 | int:PRR20C | |
| Interaction | PRR20D interactions | 8.90e-06 | 90 | 108 | 6 | int:PRR20D | |
| Interaction | PRR20E interactions | 1.73e-05 | 101 | 108 | 6 | int:PRR20E | |
| Interaction | MAML1 interactions | 4.53e-05 | 73 | 108 | 5 | int:MAML1 | |
| Interaction | IGSF5 interactions | 5.22e-05 | 14 | 108 | 3 | int:IGSF5 | |
| Interaction | DTX2 interactions | RBPMS C10orf55 RBM33 NUP98 NUP155 RBM27 NOTCH1 NOTCH2 NOTCH3 | 7.17e-05 | 330 | 108 | 9 | int:DTX2 |
| Interaction | NUP50 interactions | 9.20e-05 | 341 | 108 | 9 | int:NUP50 | |
| Interaction | NUP35 interactions | TMEM201 AUP1 RBM33 FBRS NUP98 NUP214 KMT2D NUP155 RBM27 PGLS | 9.44e-05 | 424 | 108 | 10 | int:NUP35 |
| Cytoband | 19p13.3-p13.2 | 5.08e-04 | 14 | 110 | 2 | 19p13.3-p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 6.89e-04 | 797 | 110 | 8 | chr19p13 | |
| Cytoband | 5p13 | 7.56e-04 | 17 | 110 | 2 | 5p13 | |
| Cytoband | 15q15.3 | 1.65e-03 | 25 | 110 | 2 | 15q15.3 | |
| Cytoband | 17q24.2 | 2.37e-03 | 30 | 110 | 2 | 17q24.2 | |
| GeneFamily | Nucleoporins | 1.95e-04 | 32 | 64 | 3 | 1051 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 1.96e-06 | 200 | 109 | 8 | M9463 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN | 6.08e-06 | 62 | 109 | 5 | M12517 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.30e-06 | 32 | 109 | 4 | M5903 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.96e-05 | 198 | 109 | 7 | M4451 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 2.03e-05 | 199 | 109 | 7 | M3583 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.77e-05 | 16 | 109 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.77e-05 | 16 | 109 | 3 | M2207 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLT3LG RBM33 ICAM3 ZBTB4 FBRS NUP98 AAK1 AKNA ICE1 PITPNC1 KMT2D CD8A RBM27 MLLT6 TAPBP NOTCH1 NOTCH2 IL7R | 4.22e-05 | 1492 | 109 | 18 | M40023 |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 5.45e-05 | 18 | 109 | 3 | M3506 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 6.30e-05 | 323 | 109 | 8 | M9150 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.29e-07 | 189 | 109 | 7 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.76e-06 | 160 | 109 | 6 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-06 | 161 | 109 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 165 | 109 | 6 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-06 | 167 | 109 | 6 | b742558ca92985db0a67c88f530bc375f3d3bb98 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 174 | 109 | 6 | aae7ab9df5a78716034ddfd5bd47adc69912d624 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 174 | 109 | 6 | d9489c4196d103ead8cb6279492bbe563a222e45 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.93e-06 | 177 | 109 | 6 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-06 | 178 | 109 | 6 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 182 | 109 | 6 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 182 | 109 | 6 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 182 | 109 | 6 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-06 | 183 | 109 | 6 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-06 | 184 | 109 | 6 | f9365feed31e48f3382588bab077f99c5a3f5b04 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_Naive|Control / Disease, Lineage and Cell Type | 6.75e-06 | 187 | 109 | 6 | cf8bebef36e1ec76a22f229e5c073b3a201d1b93 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 188 | 109 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 188 | 109 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 188 | 109 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.18e-06 | 189 | 109 | 6 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.18e-06 | 189 | 109 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 7.40e-06 | 190 | 109 | 6 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.40e-06 | 190 | 109 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.62e-06 | 191 | 109 | 6 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.85e-06 | 192 | 109 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | tumor_Lung-T/NK_cells|tumor_Lung / Location, Cell class and cell subclass | 8.83e-06 | 196 | 109 | 6 | 13396bb5f0dd0dce7219d3f7a1fc1fcb6b1ee134 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.83e-06 | 196 | 109 | 6 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-06 | 196 | 109 | 6 | 26f626e4df364e458431a5eccae076d1bed94ed4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-06 | 196 | 109 | 6 | 578afe58962a24874b99b0407a647b12e972344b | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 9.09e-06 | 197 | 109 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-06 | 197 | 109 | 6 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-06 | 197 | 109 | 6 | 59b1fb93a39dcf8c994d2b7dc2906dae74c57527 | |
| ToppCell | Severe_COVID-19-T/NK-CD8+_T|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.36e-06 | 198 | 109 | 6 | 584f0dc6f22bb13956a5f6950698599e382907e9 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.36e-06 | 198 | 109 | 6 | 2eb80255bacddbf778b1c9eec09f74b4cdb09b36 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-06 | 198 | 109 | 6 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-06 | 198 | 109 | 6 | ec99da4e269c4cd982a395cdac0e4487ab14ec39 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-06 | 198 | 109 | 6 | 06fdf8554148d11c0a946a7fd200edd9fa7e1965 | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.63e-06 | 199 | 109 | 6 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.63e-06 | 199 | 109 | 6 | dfdf551a292e33e3ee356629fa48a0a2f009624d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.63e-06 | 199 | 109 | 6 | ec7a1b0b71175b3a4015522bf88784eb176d59e3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK|COVID-19_Mild / Disease group, lineage and cell class | 9.91e-06 | 200 | 109 | 6 | e69416952039ca076e9b71187d8783fe567ee873 | |
| ToppCell | Caecum-ILC|Caecum / Region, Cell class and subclass | 9.91e-06 | 200 | 109 | 6 | a9a1f03b4f415da860fb52eaedb07f0743692c98 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK|COVID-19_Mild / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 6d9796153d038329a820949c0b88fd01265a1227 | |
| ToppCell | Caecum-(3)_ILC-(30)_ILC|Caecum / shred on region, Cell_type, and subtype | 9.91e-06 | 200 | 109 | 6 | ccd323997613b65f0189c0c66d76fbf273e18c03 | |
| ToppCell | Control-Lymphoid_T/NK|Control / Disease group, lineage and cell class | 9.91e-06 | 200 | 109 | 6 | b5d5eead192a22c6b5ea699fe36873809fe6e3e2 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Control-Control-Lymphocyte-T/NK|Control / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 6a399d9fa005547e5fadd3c0dafd7e4381732460 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Caecum-ILC-ILC|Caecum / Region, Cell class and subclass | 9.91e-06 | 200 | 109 | 6 | 3ac18c3ef335cb83d6a826f6c7519a5e7804929d | |
| ToppCell | Caecum-(3)_ILC|Caecum / shred on region, Cell_type, and subtype | 9.91e-06 | 200 | 109 | 6 | 6857863b3200162c250123688af2cba681afcb35 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.91e-06 | 200 | 109 | 6 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 145 | 109 | 5 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 3.41e-05 | 150 | 109 | 5 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 3.63e-05 | 152 | 109 | 5 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 158 | 109 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 158 | 109 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 158 | 109 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 5.06e-05 | 163 | 109 | 5 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 164 | 109 | 5 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 167 | 109 | 5 | d72b08b3cbc34b30a11dcf512e472b64d1606ec1 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 167 | 109 | 5 | 22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | 16c3313c4186fa327d71215f8eebc31fc12ff1c0 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | 24d1e0a05cda09ee3b80208d75cb2b601023f3bf | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-05 | 168 | 109 | 5 | 273168eefe0dae5494ac6ff5306bb307f06dc9c5 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 168 | 109 | 5 | b952af95a68888adedd03b1b60836d18524611ab | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | 4198e7fef1aaee3d85722094f3e444655d393e9e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | a3bcf0d432d8fccce50248e8d0c7a4804d69bfee | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 172 | 109 | 5 | 976d27edd5608616830624907fe050fcd3551865 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.71e-05 | 173 | 109 | 5 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.71e-05 | 173 | 109 | 5 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 177 | 109 | 5 | ffc4c675b25ffe8bd3441ce26dd0984fef4b3b88 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-05 | 177 | 109 | 5 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-05 | 179 | 109 | 5 | eadcb22045f66b37ca7ec041dd314cafa50b1911 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.88e-05 | 179 | 109 | 5 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-05 | 179 | 109 | 5 | 556f8e67475a6ece6acbe6f274b2451049000384 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.09e-05 | 180 | 109 | 5 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.09e-05 | 180 | 109 | 5 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.09e-05 | 180 | 109 | 5 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 8.09e-05 | 180 | 109 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 180 | 109 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.09e-05 | 180 | 109 | 5 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.09e-05 | 180 | 109 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-05 | 181 | 109 | 5 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 181 | 109 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-05 | 181 | 109 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.30e-05 | 181 | 109 | 5 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 181 | 109 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.52e-05 | 182 | 109 | 5 | 98c26ad34e01c4b8997d26d5d28a9935491295fa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.52e-05 | 182 | 109 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.52e-05 | 182 | 109 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.52e-05 | 182 | 109 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 5.09e-06 | 198 | 109 | 8 | 4550_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.09e-06 | 198 | 109 | 8 | 7035_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.29e-06 | 199 | 109 | 8 | 4562_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.29e-06 | 199 | 109 | 8 | 6743_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 5.48e-06 | 200 | 109 | 8 | 3322_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.43e-05 | 188 | 109 | 7 | 6451_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 3.92e-05 | 192 | 109 | 7 | 3087_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A | 3.92e-05 | 192 | 109 | 7 | 1623_DN | |
| Drug | 5155877; Down 200; 10uM; MCF7; HT_HG-U133A | 4.05e-05 | 193 | 109 | 7 | 6574_DN | |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; HL60; HG-U133A | 4.19e-05 | 194 | 109 | 7 | 1408_DN | |
| Drug | Tribenoside [10310-32-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 6328_DN | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 4.47e-05 | 196 | 109 | 7 | 592_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 2783_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 7251_UP | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A | 4.62e-05 | 197 | 109 | 7 | 1767_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 6620_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 6623_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 5844_DN | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 1229_UP | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 2082_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 5510_DN | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.61e-06 | 7 | 107 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.61e-06 | 7 | 107 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NUP98 ZNF318 NUP214 SORCS1 HOXA3 KMT2D INA TENM1 DLEC1 ATP2A3 PRRC2A CDH10 NOTCH1 NOTCH2 NOTCH3 ZNF646 | 1.65e-06 | 1074 | 107 | 16 | C0006142 |
| Disease | Squamous cell carcinoma of esophagus | 2.55e-05 | 95 | 107 | 5 | C0279626 | |
| Disease | Cerebral Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0750936 | |
| Disease | Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.01e-04 | 25 | 107 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.01e-04 | 25 | 107 | 3 | C0338070 | |
| Disease | brain cancer (implicated_via_orthology) | 1.13e-04 | 26 | 107 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.13e-04 | 26 | 107 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.13e-04 | 26 | 107 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.13e-04 | 26 | 107 | 3 | C0334582 | |
| Disease | Anaplastic astrocytoma | 1.27e-04 | 27 | 107 | 3 | C0334579 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.75e-04 | 30 | 107 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Hereditary, Type VII, Motor and Sensory Neuropathy | 1.94e-04 | 6 | 107 | 2 | C0019816 | |
| Disease | Hereditary Motor and Sensory Neuropathies | 1.94e-04 | 6 | 107 | 2 | C0027888 | |
| Disease | Glioblastoma | 1.99e-04 | 79 | 107 | 4 | C0017636 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.13e-04 | 32 | 107 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 2.52e-04 | 84 | 107 | 4 | C0334588 | |
| Disease | Dejerine-Sottas Disease (disorder) | 2.70e-04 | 7 | 107 | 2 | C0011195 | |
| Disease | multiple myeloma (is_marker_for) | 3.03e-04 | 36 | 107 | 3 | DOID:9538 (is_marker_for) | |
| Disease | platelet crit | STARD13 RBPMS GATAD2A MAP1A ZNF318 APOH TBC1D10A RBM27 LRRN2 DMRTA1 NOTCH3 | 6.88e-04 | 952 | 107 | 11 | EFO_0007985 |
| Disease | Glioblastoma Multiforme | 7.27e-04 | 111 | 107 | 4 | C1621958 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.38e-04 | 195 | 107 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | QRS duration | 7.77e-04 | 298 | 107 | 6 | EFO_0005055 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.52e-04 | 53 | 107 | 3 | C1961099 | |
| Disease | intercellular adhesion molecule 5 measurement | 9.90e-04 | 13 | 107 | 2 | EFO_0008164 | |
| Disease | Migraine Disorders | 9.90e-04 | 13 | 107 | 2 | C0149931 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 9.90e-04 | 13 | 107 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.15e-03 | 14 | 107 | 2 | DOID:627 (is_implicated_in) | |
| Disease | Malignant neoplasm of skin | 1.30e-03 | 59 | 107 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.30e-03 | 59 | 107 | 3 | C0037286 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.33e-03 | 15 | 107 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.33e-03 | 15 | 107 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.33e-03 | 15 | 107 | 2 | C0154091 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.43e-03 | 61 | 107 | 3 | C1961102 | |
| Disease | serum albumin measurement | 1.44e-03 | 592 | 107 | 8 | EFO_0004535 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.92e-03 | 18 | 107 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Carcinoma of bladder | 1.92e-03 | 18 | 107 | 2 | C0699885 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.08e-03 | 670 | 107 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | complement factor H-related protein 3 measurement | 3.39e-03 | 169 | 107 | 4 | EFO_0600056 | |
| Disease | ICAM-1 measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0004520 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.41e-03 | 24 | 107 | 2 | C0887833 | |
| Disease | sudden cardiac arrest | 3.45e-03 | 83 | 107 | 3 | EFO_0004278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPLLASLPLPTRPLQ | 11 | Q66K41 | |
| FQTSALPPALLRPAP | 366 | Q9H6B1 | |
| PLPLLQQSPATLPLA | 836 | P55198 | |
| PLLQSPPSTRLSPAR | 321 | Q4VCS5 | |
| FRTLPLVPSPLQGLT | 231 | Q9HB65 | |
| ICPPPSIPTFATLRV | 141 | P02749 | |
| PPPQRVTLTLPVLNA | 181 | O95336 | |
| PLLSVSDPFIPLQVP | 771 | Q2M2I8 | |
| RPPAVSPALTQTPLL | 886 | O60885 | |
| LNPRFISVFPRTPPT | 391 | Q6UX41 | |
| RPAPLLLNTPAIPSF | 326 | Q9UHK6 | |
| PNPSYLLPPRILSAT | 421 | Q16352 | |
| LPLASSQLPVAPQLP | 196 | Q7L3V2 | |
| LSPPARPLPVAFVLR | 111 | Q9BQC3 | |
| PTPAPTIASQPLSLR | 146 | P01732 | |
| PPLPLIFQVTPLSGR | 951 | Q93084 | |
| PSTPLPNTVPQFIAR | 116 | Q93062 | |
| VVLPIPRPPITQSSL | 376 | Q9P2N5 | |
| PIRSLFQPQPLQPLL | 331 | Q96EV2 | |
| LRVPPPLTPLSTIRN | 256 | P11161 | |
| QHPRPPIPLSLLLTE | 201 | Q8N0W5 | |
| LNFLPLPLVQSPRLS | 36 | Q9NV88 | |
| PPLPSLRPVTAFTLE | 916 | Q9HCM3 | |
| ALPRSATLPQELPVP | 441 | Q99743 | |
| PPLLLAPRASVPSVQ | 266 | Q86YP4 | |
| TPREPLPPIVTFQLI | 2296 | Q04721 | |
| PSNSGRPPQLLSPLL | 726 | Q96DN6 | |
| LPVSQRPAPSAQPLR | 111 | Q96EL1 | |
| STPDPQRVPLRLLAP | 1771 | P52948 | |
| SLVPPVTAAQFLTPP | 2471 | P46531 | |
| APLLSNLPRPASPAL | 2241 | P78559 | |
| QPSLTVRAQLAPRPP | 376 | Q96JG8 | |
| CLRTLSAPPSQPPSL | 71 | O43365 | |
| VDLTVPLPFLVPRPQ | 256 | P61550 | |
| LPVRVTSSVQPLPLP | 116 | Q9UKR0 | |
| PPTVTLLRSERPPIF | 776 | Q07954 | |
| LPLISPRSFPPSLQV | 421 | O75325 | |
| EVLPLALPSPPRQLS | 931 | Q9ULI0 | |
| IPLPFRSPSPLVSLQ | 526 | Q9UPZ3 | |
| ALQSPISPIRSPVVP | 351 | Q8N3T1 | |
| LSRLPPLPCSAPSVQ | 221 | O14498 | |
| ATAPTAPQPPLLLLL | 176 | P49771 | |
| RPRIAFQTPLPPLSA | 481 | Q1MSJ5 | |
| TRAPSITLPPTFRPL | 1356 | Q9Y4C0 | |
| ALPAQPLPLSVPSSL | 2286 | Q9UM47 | |
| APVVRTPSIQPSLLP | 1016 | P35658 | |
| LRSLLLNPPPPQTGV | 646 | Q71SY5 | |
| PPPFSLQSGILTLNP | 416 | P16871 | |
| PLPIAKVSSFPSIRP | 1406 | P00451 | |
| LTTIPPDPLFSRLPL | 216 | Q9BTN0 | |
| PQASPSTLPLTLERP | 66 | Q86UU5 | |
| LPLAQPSTPPVRRLE | 316 | O95402 | |
| VNLSVTPSPAPRTLP | 221 | Q8IZ21 | |
| LPPPKLRIPNVFSIS | 436 | Q8IVE3 | |
| PNLPEISSIRRVPLP | 76 | O75694 | |
| FVLPVTPPRLVAPRF | 216 | P32942 | |
| PLSPQLLTSPFPSVA | 241 | Q9HBE1 | |
| AQSLPSQPLLRSPLP | 671 | Q8IZL2 | |
| LPFSRPQLRVSPATP | 271 | Q9HAH7 | |
| LAPLIATPPRTSQPL | 1636 | Q9Y2F5 | |
| VLELLNFPPPSSPTL | 621 | Q6TDP4 | |
| TLPLNVNPALPLSPT | 31 | Q9NP55 | |
| PSPLSSAVPLILPQA | 501 | A0AVK6 | |
| KTPRFLTQRPPASLP | 96 | Q8N9R0 | |
| IPETLFIPRRTPTAP | 691 | Q9Y6N8 | |
| LVTTAPLPPPRALTL | 461 | Q9P218 | |
| LTPGLVPTLPFRPAL | 456 | Q5VZB9 | |
| PLPSRFIGSISPLNP | 306 | Q7Z591 | |
| FIGSISPLNPQPRPT | 311 | Q7Z591 | |
| SVFRDQPPPPLSLIT | 216 | Q86TE4 | |
| TFVLPATPPQLVSPR | 211 | P05362 | |
| PLPLSPQRQLSRDPL | 3171 | Q9NYQ7 | |
| IPLQARRPPPVLTLS | 466 | Q9Y238 | |
| SSSPAILPPLIFPAT | 561 | Q92681 | |
| PPSQLRPPSVLLATV | 111 | A6NKF1 | |
| LLPVLTPSAFPPSTA | 436 | Q9H7H0 | |
| PSFLQPVTVQLPLPS | 526 | Q9HB75 | |
| LTPAAPLTTALNPPV | 1511 | Q6ZRI0 | |
| TLPAQTLSPVLPFTP | 1851 | Q6ZRI0 | |
| PLVSSSLPQPPRDVL | 226 | Q9Y3M8 | |
| RVSPLPLSPLSPATF | 121 | Q9UK53 | |
| RAPSITLPPTFRPLL | 351 | Q9HDB5 | |
| PTQANPALPSLPTLL | 436 | Q9H6K5 | |
| LQAPLSLPASPPLQT | 656 | Q9H6K5 | |
| TRVLPSPARPFPASL | 2031 | P48634 | |
| PVRSFLQPPKPLSSL | 541 | Q8ND83 | |
| LSPTSPLLNLPQVVP | 466 | Q8N196 | |
| FISPNPIVLPSPLTS | 981 | Q9UKZ4 | |
| VASFPVALPLQPPTL | 611 | Q96NU1 | |
| PAQIPTLVPTPALAR | 66 | P59797 | |
| VDSPPPLSFLTLLPV | 521 | Q9NZP6 | |
| PPPPPVFSLLKISQR | 291 | Q14CN2 | |
| PKPTLPSPSRLTLFV | 61 | Q5SWW7 | |
| CASTRLPPTPLLLFP | 146 | Q9Y679 | |
| ITLQPLPPTAFIPTL | 1281 | A4D1E1 | |
| SVCTLPPPFTLSLPL | 586 | A0A1B0GUW6 | |
| LSLPLVPPRSFVPPQ | 596 | A0A1B0GUW6 | |
| LLPLASALQPTPLPF | 41 | Q8WTU2 | |
| ATPIPLPLAPFTQLT | 606 | Q9H6E5 | |
| RFPPTLPRPAVAILS | 696 | O75717 | |
| LAQPQSPFRALLPSP | 581 | Q6ZQQ2 | |
| PVLSLSSLLRPQPEP | 131 | O15533 | |
| LPPATRITPNFPNTL | 41 | Q9P1D8 | |
| IFPPAISISSIPLLP | 251 | Q9UKF7 | |
| APPLPIPASSLLSNL | 196 | O15015 | |
| REALLTSAPLPLPPA | 56 | Q9P1Z0 | |
| SLFIPSPPSFLPLAN | 416 | Q5SNT2 | |
| LSLPPRPSASLFQAP | 431 | Q569K4 | |
| SPLPRQRFPVPDSVL | 36 | Q9BQ65 | |
| IIPPPQAPLFLSSLT | 256 | A0PK05 | |
| PATPLPLVVRPLFSV | 66 | Q8WY21 | |
| RPALQPSPSIRLPLD | 401 | Q9BXI6 | |
| VLPPSVPFFLLLPSS | 511 | Q8N2I2 | |
| ISPSLITRAPPRPQL | 146 | P0DJG4 | |
| LFSVLVRPPPPLSSV | 1531 | Q5VUA4 | |
| PFPLTPSLRPQVSSI | 76 | Q9P2D8 | |
| SRLSPLPVVSRLSPP | 651 | O14686 | |
| ALSPVIPLIPRASIP | 4736 | O14686 | |
| IPLIPRASIPVFPDT | 4741 | O14686 | |
| QVATTLRIPVSPPLP | 496 | E9PAV3 |